» Articles » PMID: 37877503

DsbA-L: A Promising Therapeutic Target for Metabolic Diseases

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2023 Oct 25
PMID 37877503
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing incidence of metabolic diseases, including obesity and diabetes, is a serious social public problem. Therefore, there is an urgent need to find effective prevention and treatment measures for these diseases. DsbA-L is a protein that is widely expressed in many tissues and is closely related to metabolism. Emerging evidence shows that DsbA-L plays an important role in antioxidative stress, promoting the synthesis and secretion of adiponectin and maintaining mitochondrial homeostasis, and the abnormalities of these functions are also closely related to the occurrence and development of metabolic diseases. Here, we reviewed the tissue expression patterns and regulatory factors of DsbA-L, summarized its biological functions and the current research progress of DsbA-L in metabolic diseases, and found that DsbA-L may be a promising target for metabolic diseases.

References
1.
Li H, Zhou D, Gan R, Huang S, Zhao C, Shang A . Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients. 2021; 13(9). PMC: 8470858. DOI: 10.3390/nu13093211. View

2.
Day E, Ford R, Steinberg G . AMPK as a Therapeutic Target for Treating Metabolic Diseases. Trends Endocrinol Metab. 2017; 28(8):545-560. DOI: 10.1016/j.tem.2017.05.004. View

3.
Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q . Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother. 2020; 133:110984. DOI: 10.1016/j.biopha.2020.110984. View

4.
Yang M, Luo S, Yang J, Chen W, He L, Liu D . Crosstalk between the liver and kidney in diabetic nephropathy. Eur J Pharmacol. 2022; 931:175219. DOI: 10.1016/j.ejphar.2022.175219. View

5.
Kollias A, Ulbig M . Diabetic retinopathy: Early diagnosis and effective treatment. Dtsch Arztebl Int. 2010; 107(5):75-83. PMC: 2828250. DOI: 10.3238/arztebl.2010.0075. View